rs1799944

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000059.4(BRCA2):​c.2971A>G​(p.Asn991Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0432 in 1,613,690 control chromosomes in the GnomAD database, including 2,250 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. N991K) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.047 ( 247 hom., cov: 32)
Exomes 𝑓: 0.043 ( 2003 hom. )

Consequence

BRCA2
NM_000059.4 missense

Scores

14

Clinical Significance

Benign reviewed by expert panel B:37O:2

Conservation

PhyloP100: -0.0400

Publications

151 publications found
Variant links:
Genes affected
BRCA2 (HGNC:1101): (BRCA2 DNA repair associated) Inherited mutations in BRCA1 and this gene, BRCA2, confer increased lifetime risk of developing breast or ovarian cancer. Both BRCA1 and BRCA2 are involved in maintenance of genome stability, specifically the homologous recombination pathway for double-strand DNA repair. The largest exon in both genes is exon 11, which harbors the most important and frequent mutations in breast cancer patients. The BRCA2 gene was found on chromosome 13q12.3 in human. The BRCA2 protein contains several copies of a 70 aa motif called the BRC motif, and these motifs mediate binding to the RAD51 recombinase which functions in DNA repair. BRCA2 is considered a tumor suppressor gene, as tumors with BRCA2 mutations generally exhibit loss of heterozygosity (LOH) of the wild-type allele. [provided by RefSeq, May 2020]
BRCA2 Gene-Disease associations (from GenCC):
  • BRCA2-related cancer predisposition
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • breast-ovarian cancer, familial, susceptibility to, 2
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • Fanconi anemia complementation group D1
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), ClinGen, Ambry Genetics
  • pancreatic cancer, susceptibility to, 2
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • sarcoma
    Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
  • hereditary breast ovarian cancer syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Fanconi anemia
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • medulloblastoma
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.002044946).
BP6
Variant 13-32337326-A-G is Benign according to our data. Variant chr13-32337326-A-G is described in ClinVar as Benign. ClinVar VariationId is 41545.Status of the report is reviewed_by_expert_panel, 3 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.106 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000059.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
BRCA2
NM_000059.4
MANE Select
c.2971A>Gp.Asn991Asp
missense
Exon 11 of 27NP_000050.3A0A7P0T9D7
BRCA2
NM_001432077.1
c.2971A>Gp.Asn991Asp
missense
Exon 11 of 27NP_001419006.1A0A7P0T9D7
BRCA2
NM_001406720.1
c.2971A>Gp.Asn991Asp
missense
Exon 11 of 27NP_001393649.1A0A8V8TPZ2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
BRCA2
ENST00000380152.8
TSL:5 MANE Select
c.2971A>Gp.Asn991Asp
missense
Exon 11 of 27ENSP00000369497.3P51587
BRCA2
ENST00000544455.6
TSL:1
c.2971A>Gp.Asn991Asp
missense
Exon 11 of 27ENSP00000439902.1P51587
BRCA2
ENST00000530893.7
TSL:1
c.2602A>Gp.Asn868Asp
missense
Exon 11 of 27ENSP00000499438.2A0A590UJI7

Frequencies

GnomAD3 genomes
AF:
0.0468
AC:
7127
AN:
152182
Hom.:
244
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0425
Gnomad AMI
AF:
0.0263
Gnomad AMR
AF:
0.0984
Gnomad ASJ
AF:
0.0441
Gnomad EAS
AF:
0.0998
Gnomad SAS
AF:
0.114
Gnomad FIN
AF:
0.0148
Gnomad MID
AF:
0.0380
Gnomad NFE
AF:
0.0345
Gnomad OTH
AF:
0.0497
GnomAD2 exomes
AF:
0.0541
AC:
13545
AN:
250428
AF XY:
0.0568
show subpopulations
Gnomad AFR exome
AF:
0.0422
Gnomad AMR exome
AF:
0.0727
Gnomad ASJ exome
AF:
0.0382
Gnomad EAS exome
AF:
0.102
Gnomad FIN exome
AF:
0.0156
Gnomad NFE exome
AF:
0.0351
Gnomad OTH exome
AF:
0.0490
GnomAD4 exome
AF:
0.0428
AC:
62505
AN:
1461390
Hom.:
2003
Cov.:
33
AF XY:
0.0453
AC XY:
32963
AN XY:
726978
show subpopulations
African (AFR)
AF:
0.0417
AC:
1396
AN:
33458
American (AMR)
AF:
0.0758
AC:
3387
AN:
44690
Ashkenazi Jewish (ASJ)
AF:
0.0413
AC:
1078
AN:
26124
East Asian (EAS)
AF:
0.119
AC:
4715
AN:
39634
South Asian (SAS)
AF:
0.115
AC:
9907
AN:
86162
European-Finnish (FIN)
AF:
0.0152
AC:
808
AN:
53316
Middle Eastern (MID)
AF:
0.0562
AC:
324
AN:
5762
European-Non Finnish (NFE)
AF:
0.0342
AC:
38046
AN:
1111860
Other (OTH)
AF:
0.0471
AC:
2844
AN:
60384
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
3359
6718
10076
13435
16794
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1566
3132
4698
6264
7830
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0469
AC:
7149
AN:
152300
Hom.:
247
Cov.:
32
AF XY:
0.0493
AC XY:
3669
AN XY:
74478
show subpopulations
African (AFR)
AF:
0.0425
AC:
1768
AN:
41572
American (AMR)
AF:
0.0991
AC:
1516
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.0441
AC:
153
AN:
3466
East Asian (EAS)
AF:
0.0997
AC:
516
AN:
5176
South Asian (SAS)
AF:
0.114
AC:
550
AN:
4828
European-Finnish (FIN)
AF:
0.0148
AC:
157
AN:
10628
Middle Eastern (MID)
AF:
0.0340
AC:
10
AN:
294
European-Non Finnish (NFE)
AF:
0.0345
AC:
2346
AN:
68016
Other (OTH)
AF:
0.0516
AC:
109
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
335
670
1006
1341
1676
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
84
168
252
336
420
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0390
Hom.:
640
Bravo
AF:
0.0489
TwinsUK
AF:
0.0299
AC:
111
ALSPAC
AF:
0.0327
AC:
126
ESP6500AA
AF:
0.0386
AC:
170
ESP6500EA
AF:
0.0366
AC:
314
ExAC
AF:
0.0531
AC:
6448
Asia WGS
AF:
0.111
AC:
385
AN:
3476
EpiCase
AF:
0.0363
EpiControl
AF:
0.0391

ClinVar

ClinVar submissions
Significance:Benign
Revision:reviewed by expert panel
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
11
Breast-ovarian cancer, familial, susceptibility to, 2 (12)
-
-
9
not specified (10)
-
-
6
not provided (6)
-
-
4
Hereditary breast ovarian cancer syndrome (4)
-
-
2
Familial cancer of breast (2)
-
-
2
Hereditary cancer-predisposing syndrome (2)
-
-
1
Breast carcinoma (1)
-
-
1
Fanconi anemia complementation group D1 (1)
-
-
1
Medulloblastoma;C0346153:Familial cancer of breast;C0376358:Prostate cancer;C1838457:Fanconi anemia complementation group D1;C2675520:Breast-ovarian cancer, familial, susceptibility to, 2;C2751641:Glioma susceptibility 3;C3150546:Pancreatic cancer, susceptibility to, 2;CN033288:Wilms tumor 1 (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.054
BayesDel_addAF
Benign
-0.71
T
BayesDel_noAF
Benign
-0.68
CADD
Benign
0.24
DANN
Benign
0.15
Eigen
Benign
-1.4
Eigen_PC
Benign
-1.3
FATHMM_MKL
Benign
0.0056
N
MetaRNN
Benign
0.0020
T
MetaSVM
Benign
-1.0
T
PhyloP100
-0.040
PrimateAI
Benign
0.27
T
PROVEAN
Benign
2.1
N
REVEL
Benign
0.040
Sift
Benign
1.0
T
Sift4G
Benign
1.0
T
Vest4
0.051
MPC
0.021
ClinPred
0.00095
T
GERP RS
3.1
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
gMVP
0.063
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1799944; hg19: chr13-32911463; COSMIC: COSV66450658; COSMIC: COSV66450658; API